Similar logic was used when IPIX applied for grant
Post# of 72440
Quote:
On a related note, the Company has submitted a preliminary summary of Brilacidin’s potential as a novel coronavirus treatment to the Biomedical Advanced Research and Development Authority (BARDA), which is dedicated to rapidly identifying and funding medical countermeasures to the COVID-19 outbreak.
http://www.ipharminc.com/press-release/2020/2...s-covid-19
Below is a list of companies and the amount awarded by BARDA to fight COVID-19.
https://www.medicalcountermeasures.gov/app/ba...VID19.aspx
Four months later, Leo has not updated shareholders on the status. Some said maybe the government has not heard of Brilacidin, to that I say the FDA granted QIDP designation to B in 2014.